Cadralazine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 64241-34-5 |
| ATC code | C02DB04 |
| PubChem | CID 2515 |
| ChemSpider | 2420 |
| UNII | 8T96I3U713 |
| Chemical data | |
| Formula | C12H21N5O3 |
| Mol. mass | 283.33 g/mol |
|
|
|
|
| |
|
Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.
References [edit]
|
|||||||||||||||||||||
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |